
Ayelet Rubenstein
Internal Medicine Residency · New York Presbyterian Hospital
Credentials: · ·
History
Research
CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
Nature Communications · 2022 · 29 citations
Systematic review or meta-analysis · Hematological Oncology · 2022 · 12 citations
British Journal of Haematology · 2024 · First of 9 authors · 11 citations

2 papers

1 paper
- DD
1 paper
- EB
1 paper

1 paper

1 paper
- JC
1 paper

1 paper


